PlantForm

PlantForm Corporation is a privately-held Canadian biopharmaceutical company focused on the rapid development and production of specialty antibody and protein drugs using its proprietary vivo XPRESS manufacturing platform. The plant-based vivo XPRESS system uses genetically modified plants to produce biopharmaceuticals in fully contained greenhouse environments, delivering high drug expression levels and mammalian-type glycosylation to reduce the risk of an unwanted immune reaction, while making it easier, faster and less expensive to produce approved biologic drugs for novel indications and new markets.